News
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug ...
As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...
Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...
A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study.
If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...
Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...
Novo Nordisk NOVO.B3.59%increase; green up pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense ...
Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results